Blood-brain barrier modulation for targeted central nervous system drug delivery in neurodegenerative and demyelinating disorders.

Uti DE, Alum EU, Okpe JM, Egbung JE, Mbah JO

Open source

DOI
10.1016/j.tice.2026.103524
Published
2026 Aug
Container
Tissue & cell
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.tice.2026.103524,
  title = {Blood-brain barrier modulation for targeted central nervous system drug delivery in neurodegenerative and demyelinating disorders.},
  author = {Uti DE and Alum EU and Okpe JM and Egbung JE and Mbah JO},
  year = {2026},
  journal = {Tissue \& cell},
  doi = {10.1016/j.tice.2026.103524},
  url = {https://doi.org/10.1016/j.tice.2026.103524}
}

RIS

TY  - JOUR
TI  - Blood-brain barrier modulation for targeted central nervous system drug delivery in neurodegenerative and demyelinating disorders.
AU  - Uti DE
AU  - Alum EU
AU  - Okpe JM
AU  - Egbung JE
AU  - Mbah JO
PY  - 2026
JO  - Tissue & cell
DO  - 10.1016/j.tice.2026.103524
UR  - https://doi.org/10.1016/j.tice.2026.103524
ER  - 

APA

DE, U., EU, A., JM, O., JE, E., & JO, M. (2026). Blood-brain barrier modulation for targeted central nervous system drug delivery in neurodegenerative and demyelinating disorders.. Tissue & cell. https://doi.org/10.1016/j.tice.2026.103524

Source records